Advances in the molecular genetics of obesity

Current Opinion in Genetics and Development

Volumn 9, Issue 3, 1999, Pages 283-288

  North, Michael A ^a  

^a Axys Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LEPTIN; MELANOCORTIN;

ANGIOGENESIS; BODY WEIGHT; CYTOKINE PRODUCTION; FEEDING; GENE MUTATION; MOLECULAR GENETICS; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033153191     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(99)80042-2     Document Type: Article

References (64)

1. Clement K, Garner C, Hager J, Philippi A, LeDuc C, Carey A, Harris TJ, Jury C, Cardon LR, Basdevant A et al.: Indication for linkage of the human OB gene region with extreme obesity. Diabetes 1996, 45:687-690.
2. Maffei M, Stoffel M, Barone M, Moon B, Dammerman M, Ravussin E, Bogardus C, Ludwig DS, Flier JS, Talley M et al.: Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 1996, 45:679-682.
3. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM et al.: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392:398-401. An important paper confirming - at least in the case of the leptin pathway - an underlying assumption of the many studies where mouse obesity genes have been isolated: that bodyweight regulation in the mouse is functionally equivalent to that in man. This paper demonstrates that that leptin is a key physiological regulator of the same endocrine functions in man as previously described in the mouse (in both species, loss of function leads to hypercortisolaemia, alterations in glucose homeostasis, dyslipidaemia, infertility and obesity).
4. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA et al.: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387:903-908.
5. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD: A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998, 18:213-215. Along with reference [3••], this paper provides confirmation that inferences drawn from studies of mouse models for human obesity can have strong predictive power.
6. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269:546-549.
7. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neurocrine response to fasting. Nature 1996, 382:250-252.
8. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE et al.: Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495.
9. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996, 379:632-635.
10. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al.: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nat Med 1995, 1:1155-1161.
11. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
12. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L: A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998, 393:684-688. Leptin is synthesized and released in response to increased energy storage in adipose tissue but it is still not known how incoming energy is sensed and transduced into increased expression of the leptin gene. The authors of this paper describe evidence of inducible leptin expression in skeletal muscle and indicate an important biochemical link between increased availability of nutrients and leptin expression.
13. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS: Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278:135-138.
14. Vaisse C, Clement K, Guy-Grand B, Froguel P: A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998, 20:113-114. See annotation [15•].
15. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998, 19:155-157. Together with [14•], this paper demonstrates a functional equivalence in the central and peripheral melanocortin pathways between mouse and man. Mutation of the hypothalamic MC4R receptor leads to obesity in both species, whereas mutation in POMC lead to both obesity and pigmentation defects by inhibiting signaling of MC1R as well as MC4R, analogous to the effects of ectopic expression of Agouti protein in lethal yellow (Ay/a) mice.
16. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH: Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995, 10:135-142.
17. Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC, O'Rahilly S: Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997, 16:303-306.
18. Noben-Trauth K, Naggert JK, North MA, Nishina PM: A candidate gene for the mouse mutation tubby. Nature 1996, 380:534-538.
19. Hagstrom SA, North MA, Nishina PL, Berson EL, Dryja TP: Recessive mutations in the gene encoding the tubby-like protein TULP1 in patients with retinitis pigmentosa. Nat Genet 1998, 18:174-176. The human gene TULP1 is related in sequence to the mouse obesity gene tubby. Mutations in tubby lead to progressive retinal degeneration, as well as maturity onset obesity. This paper demonstrates that TULP1 mutations are a rare cause of autosomal recessive retinitis pigmentosa in man and establishes the functional equivalence of tubby family function between mouse and man.
20. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE: The body-mass index of twins who have been reared apart. New Engl J Med 1990, 322:1483-1487.
21. Carmelli D, Cardon LR, Fabsitz R: Clustering of hypertension, diabetes, and obesity in adult male twins:Same genes or same environments? Am J Hum Genet 1994, 55:566-573.
22. Norman RA, Tataranni PA, Pratley R, Thompson DB, Hanson RL, Prochazka M, Baier L, Ehm MG, Sakul H, Foroud T et al.: Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet 1998, 62:659-668
23. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, Stern MP, MacCluer JW, Blangero J: A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997, 15:273-276.
24. Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, Vaillant E, Lorentz N, Basdevant A, Clement K et al.: A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 1998, 20:304-308. This paper provides some of the most convincing evidence to date for a major gene effect in human obesity. A major predisposing gene in the French population is localized to a region on chromosome 10p, with Lod score 4.85.
25. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998. 394:897-901. Impaired cell-mediated immunity and reduced levels of leptin are both features of low body weight in humans and malnutrition predisposes to death from infectious diseases. This paper demonstrates that leptin has a specific effect on T-lymphocyte responses, differentially regulating the proliferation of naïve and memory T cells leading to increased Th1 and suppressed Th2 cytokine production.
26. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR: Biological action of leptin as an angiogenic factor. Science 1998, 281:1683-1686. This paper demonstrates a potentially important peripheral function for leptin in the regulation of angiogenesis. The leptin receptor is shown to be expressed in human and, in vivo, leptin induces neovascularization in corneas from normal rats but not in corneas from fa/fa Zucker rats, which lack functional leptin receptor.
27. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, MoizoL, Lehy T, Guerre-Millo M, Le Marchand-Brustel Y, Lewin MJ: The stomach is a source of leptin. Nature 1998, 394:790-793. Leptin has previously been reported to be only secreted by adipocytes. This paper demonstrates that leptin messenger RNA and leptin protein are present in rat gastric epithelium and that cells in the glands of the gastric fundic mucosa are immunoreactive for leptin. The physiological function of this previously unsuspected source of leptin is unknown but may be critical to the short-term regulation of food intake (control of meal size, etc.).
28. Bjorbaek C, Uotani S, da Silva B, Flier JS: Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997, 272:32686-32695.
29. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998, 18:559-572. This extremely comprehensive study reports distribution of leptin receptor in several regions of the CNS, including the choroid plexus, cerebral cortex, hippocampus, thalamus, and hypothalamus. In the hypothalamus, expression was detected in the supraoptic nucleus and paraventricular nucleus, penventricular nucleus, arcuate nucleus, and lateral hypothalamus.
30. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM: Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996, 14:95-97.
31. Carpenter LR, Farruggella TJ, Symes A, Karow ML, Yancopoulos GD, Stahl N: Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with ob receptor. Proc Natl Acad Sci USA 1998, 95:6061-6606. This paper demonstrates that activation of the leptin receptor induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and indicates that SHP-2 is a negative regulator of STAT3-mediated gene induction. Blocking the interaction of SHP-2 with the leptin receptor is therefore a potential therapy for leptin resistance.
32. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS: Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998, 1:619-625. This paper demonstrates that peripheral leptin administration to ob/ob mice rapidly induces SOCS-3 mRNA expression in the hypothalamus. SOCS-3 - a member of the suppressors of cytokine signaling (SOCS) family of proteins - is highly expressed in the arcuate and dorsomedial hypothalamic nuclei in Agouti mice, a model of leptin-resistant murine obesity. SOCS-3 is therefore a potential mediator of leptin resistance.
33. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford ML: Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 1997, 390:521-525.
34. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL et al.: A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996, 382:168-171.
35. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A et al.: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995, 377:530-532.
36. Mercer JG, Moar KM, Rayner DV, Trayhurn P, Hoggard N: Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice. FEBS Lett 1997, 402:185-188.
37. Erickson JC, Hollopeter G, Palmiter RD: Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996, 274:1704-1707.
38. Erickson JC, Clegg KE, Palmiter RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996, 381:415-418.
39. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO: Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994, 371:799-802.
40. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
41. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL: Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 1997, 11:593-602.
42. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K: Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 1998, 249:107-110.
43. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore J, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD et al.: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
44. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL: Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 1997, 17:273-274.
45. Boston BA, Blaydon KM, Varnerin J, Cone RD: Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 1997, 278:1641-1644. This elegant genetic study demonstrates that in the AY/a mouse, obesity is independent of leptin action and resistance to leptin results from desensitization of leptin signaling.
46. Dinulescu DM, Fan W, Boston BA, McCall K, Lamoreux ML, Moore KJ, Montagno J, Cone RD: Mahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti. Proc Natl Acad Sci USA 1998, 95:12707-12712. This paper demonstrates that the mahogany mutation blocks the obesity, hyperinsulinemia, and increased linear growth induced by ectopic expression of the agouti peptide. It also demonstrates, by genetic tests, that mahogany acts independently of the melanocortin pathway in the control of metabolic rate and feeding behavior.
47. Flier JS, Maratos-Flier E : Obesity and the hypothalamus: Novel peptides for new pathways. Cell 1998, 92:437-440.
48. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N et al.: Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998, 393:72-76. This paper demonstrates that CART (cocaine- and amphetamine-regulated transcript) is a satiety factor which can be regulated by leptin. In animal models of obesity with disrupted leptin signaling, CART mRNA is almost absent from the arcuate nucleus whereas peripheral administration of leptin to obese mice stimulates CART mRNA expression.
49. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S et al: Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585. This paper describes two novel neuropeptides that bind and activate two closely related orphan G protein-coupled receptors. These peptides, termed orexm-A and -B, are localized in the lateral and posterior hypothalamus. When administered centrally, these peptides strongly stimulate food consumption.
50. Campfield LA, Smith FJ, Burn P: Strategies and potential molecular targets for obesity treatment. Science 1998, 280:1383-1387.
51. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995, 1:1311-1314.
52. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D: Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat Med 1996, 2:589-593.
53. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 1996. 348:159-161.
54. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis HR Jr: Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997, 99:385-390.
55. Garlid KD, Jaburek M, Jezek P: The mechanism of proton transport mediated by mitochondrial uncoupling proteins. FEBS Lett 1998, 438:10-14.
56. Gura T: Uncoupling proteins provide new clue to obesity's causes. Science 1998, 280:1369-1370.
57. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366:740-742.
58. Enerback S, Jacobsson A, Simpson EM, Guerra C, Yamashita H, Harper ME, Kozak LP: Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997 387:90-94.
59. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH: Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997, 15:269-272. This paper reports the discovery of UCP2, which has 59% amino-acid identity to UCP1 and is upregulated in white fat in response to fat feeding. UCP2 is reported to map to regions of human chromosome 11 and mouse chromosome 7 that have been linked to hyperinsulinaemia and obesity.
60. Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP: Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 1997, 408:39-42.
61. Matsuda J, Hosoda K, Itoh H, Son C, Doi K, Tanaka T, Fukunaga Y, Inoue G, Nishimura H, Yoshimasa Y et al.: Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: Their gene expression in rats fed high-fat diet. FEBS Lett 1997, 24:200-204.
62. Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricquier D, Collins S: Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci USA 1998, 95:4061-4065. This paper demonstrates that the consumption of a high-fat diet selectively regulates UCP2 expression in white fat and UCP1 expression in brown fat, and that resistance to obesity is correlated with this early, selective induction of UCP1 and UCP2 but is not associated with changes in expression of UCP3.
63. Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP, Easlick J, Warden CH, Pecqueur C, Raimbault S et al.: Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians. Hum Mol Genet 1998, 7:1431-1435. This paper reports a preliminary but potentially very interesting conclusion that allelic variation within the UCP2 gene (situated at chromosomal position 11q13) can contribute to variation in resting metabolic rate which may, in turn, contribute to overall body-fat content with age.
64. Otabe S, Clement K, Rich N, Warden C, Pecqueur C, Neverova M, Raimbault S, Guy-Grand B, Basdevant A, Ricquier D et al: Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: Lack of association between new UCP 2 polymorphisms and obesity in French Caucasians. Diabetes 1998, 47:840-842.